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The coccidia are in the phylum Apicomplexa and may be grouped into numerous genera consisting of more than a thousand species; however, this discussion will be restricted to the genus Eimeria, which infects chickens and turkeys. These homogenous intracellular protozoans possess several characteristics that make disease control and eradication extremely difficult under commercial conditions. Coccidia are ubiquitous to commercial poultry production. Although nearly all commercial birds receive some form of preventative therapy, field cases of coccidiosis are still common. Several techniques can be used to diagnose coccidiosis. However, we will describe only those macro-and microscopic techniques routinely used during field evaluations.
The greatest impact of coccidiosis on the poultry industry is the cost of prophylaxis and the production losses associated with clinical disease. Coccidia are very easy to identify. However, the presence of the parasite does not confirm the presence of clinical disease or a reduction in growth performance. Therefore, the clinician must be able to differentiate between coccidiosis (true clinical disease) and coccidiasis (mild infections not associated with significant economic loss). Although mortality can occur during severe outbreaks, it is rare and most economic losses are attributed to a reduction in production efficiency. Etiology. Coccidiosis is unique in that it affects almost every animal species, yet individual species of coccidia are host specific. In other words, each species of Eimeria, for all practical purposes, infects only one species of poultry . In addition to species specificity, there is immunogenic specificity. Although coccidia tend to be very immunogenic, exposure to one species will not provide significant protection against other species. Although there are exceptions, the life cycle of c occidian associated with commercial poultry is basically confined to the enteric system of the host and the disease In the sexual life phase (gamogony), microgametes released from the microgametocyte will fertilize the macrogametes. The fertil ized macrogamete will develop a protective cell wall becoming an oocyst. As the fertilized oocyst matures, the epithelial cell membrane ruptures releasing the oocyst. The unsporulated oocyst enters the intestinal lumen to be shed in the host's fecal materi al. The time between the ingestion of a sporulated oocyst and the initial appearance of an unsporulated oocyst in the feces is known as the pre-patent period. The pre-patent period will average between four and eight days depending upon the infective speci es. Shedding may continue for many days to more than a week after the appearance of the first oocyst (patent period). acervulina's prevalence, reproductive potential, and adverse effects on production efficiency, may make it the single most economically impac tive parasite in the chicken industry in some geographical areas.
Turkey Species. Of the seven species of Eimeria found in turkeys, four are considered to be significantly pathogenic. While E. dispersa is less pathogenic than E. meleagrimitis, E. adenoeides, and E. gallopavonis, it too can reduce growth performance. For the most part, coccidial infections in turkeys do not produce discrete lesions to the extent of those produced in chickens. In addition, the presence of nonpathogenic species (E. innocua, E. melagridis, and E. subrotunda) of turkey coccidia can make diagnosis and microscopic speciation difficult. Eimeria adenoeides and E. meleagrimitis appear to be the most common species found in commercial turkeys. 
